Vivo Bio Tech Ltd (VIVOBIOT) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Vivo Bio Tech Ltd reported sales of ₹14.28 Cr, operating profit of ₹5.05 Cr (OPM 35.36%) and net profit of ₹0.19 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
VIVOBIOT quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 12.04 12.21 12.29 12.51 13.11 13.51 14.2 14.28 Expenses 6.45 6.67 7.27 7.03 7.69 8.02 9.75 9.23 Operating Profit 5.59 5.54 5.02 5.48 5.42 5.49 4.45 5.05 OPM 46.43% 45.37% 40.85% 43.8% 41.34% 40.64% 31.34% 35.36% Other Income 4.63 0.01 0.15 0.14 0.13 0.14 0.03 0.06 Interest 2.06 1.84 1.68 1.5 1.47 1.4 1.48 1.24 Depreciation 2.29 2.25 2.25 2.64 2.57 2.66 2.75 3.53 Profit before tax 5.87 1.46 1.24 1.48 1.51 1.57 0.25 0.34 Tax 10.73% 43.84% 14.52% 9.46% 42.38% 20.38% 2,164% 44.12% Net Profit 5.23 0.82 1.06 1.34 0.87 1.25 -5.16 0.19 EPS in Rs 3.51 0.51 0.62 0.67 0.39 0.57 -2.33 0.09
VIVOBIOT profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 51.39 52.23 45.45 46.67 53.33 55.1 Expenses 35.3 30.39 24.19 26.11 32.48 34.69 Operating Profit 16.09 21.84 21.26 20.56 20.85 20.41 OPM 31.31% 41.82% 46.78% 44.05% 39.1% 37.04% Other Income 0.1 0.04 0.04 4.8 0.44 0.36 Interest 4.27 7.99 7.95 7.55 5.85 5.59 Depreciation 7.45 9.27 9.29 9.02 10.63 11.51 Profit before tax 4.47 4.62 4.06 8.79 4.81 3.67 Tax 50.78% 42.64% 37.93% 17.18% 135.55% - Net Profit 2.2 2.65 2.53 7.28 -1.71 -2.85 EPS in Rs 1.54 1.78 1.7 4.24 -0.77 -1.28 Dividend Payout 0% 0% 0% 0% 0% -
VIVOBIOT balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 14.9 14.9 17.16 22.1 22.19 Reserves 36.97 39.5 60.74 74.67 70.97 Borrowings 62.39 73.06 54.03 56.53 67.38 Other Liabilities 8.77 9.67 11.3 11.88 17.89 Total Liabilities 123.03 137.13 143.23 165.18 178.43 Fixed Assets 88.87 80.37 88.24 83.16 123.02 CWIP 1.9 9.21 12.84 12.86 4.81 Investments 0 0 0 0 21.91 Other Assets 32.26 47.55 42.15 69.16 28.69 Total Assets 123.03 137.13 143.23 165.18 178.43
VIVOBIOT cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 16.64 14.83 15.52 11.83 - Cash from Investing Activity -51.11 -4 -7.95 -15.84 - Cash from Financing Activity 35.02 -11.18 -7.56 3.9 - Net Cash Flow 0.55 -0.34 0.01 -0.11 - Free Cash Flow -34.47 10.83 7.57 -4.01 - CFO/OP 118% 77% 80% 65% -
VIVOBIOT ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 85.37 86.52 94.76 87.98 80.42 Inventory Days 312.99 429.7 831.44 491.08 365.9 Days Payable 74.02 50.68 100.49 61.78 88 Cash Conversion Cycle 324.35 465.53 825.71 517.29 358.32 Working Capital Days 8.1 38.09 63.76 100.26 -22.24 ROCE 9.29% 11.02% 9.94% 9.04% 7.29%